We have been a member of the AMR Industry Alliance since its inception in May 2017 at the B20 Health Conference in Berlin. The AMR Industry Alliance fuses the two initiatives of the Davos Declaration and the UN Industry Roadmap, and brings together a wide-range of stakeholders from research-based pharmaceutical companies, generics (among which is Centrient Pharmaceuticals), diagnostics, and biotech companies, and associations representing these industries. The AMR Industry Alliance ensures that signatories collectively deliver on the specific commitments made in the Declaration and the Roadmap and will measure progress made in the fight against antimicrobial resistance.
One of the initial key objectives of the Alliance is to develop a reporting framework to track progress, identify gaps and set targets for the future. This will increase accountability from industry and inform decision-making at global level. As an acknowledged leader of sustainable antibiotics, Centrient Pharmaceuticals is member of the Industry Alliance Board, headed by the IFPMA.
The first progress report was launched in 2018 at the World Economic Forum in Davos for the two year anniversary of the Declaration. The Alliance showed how – from Davos 2016 to Davos 2018 – the industry has been delivering on its commitments and demonstrating this through concrete actions, by adopting a more practical approach and leading by example to curb antimicrobial resistance.
Read more about AMR industry alliance.
In November 2016 we joined the Pharmaceutical Supply Chain Initiative (PSCI), a group of 24 pharmaceutical and healthcare companies who have joined forces to promote responsible supply chain management, and better business conditions across the industry. Joining PSCI enables us to play a leading role in establishing industry-wide guidelines that ensure antibiotics are produced responsibly and sustainably, and cover the entire value chain.
Read more about PSCI.
In 2015 we joined the Together for Sustainability (TfS) initiative, an industry initiative founded by the Chief Procurement Officers of six multinational chemical companies in 2011. Its purpose is to develop and implement a global audit program to assess and improve sustainability practices within the supply chains of the chemical industry. The TfS ‘EcoVadis assessment’ is used among our suppliers. The results of assessments and audits are shared among TfS member companies on the EcoVadis platform.
So far, TfS has carried out over 6,000 supplier assessments, and more than 700 audit reports are available on EcoVadis, performed by more than 300 qualified auditors. In 2015 and 2016, EcoVadis assessments were carried out at 27 of our suppliers (14 initiated by Centrient Pharmaceuticals), covering almost 70% of our third-party spend. Whenever a supplier’s assessment score falls below target level, we set up a Corrective Action Plan (CAP) together with the supplier, or schedule an audit to ensure that our picture of their sustainability performance is accurate.
Read more about TfS.